Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dengue Shock Syndrome”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Post-approval studies (Phase 4)UnknownNCT02673840
What this trial is testing

Ketotifen as a Treatment for Vascular Leakage During Dengue Fever

Who this might be right for
Dengue FeverPleural Effusion
National University Hospital, Singapore 110
Testing effectiveness (Phase 2)Study completedNCT00880893
What this trial is testing

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue Virus+1 more
Sanofi Pasteur, a Sanofi Company 1,198
Early research (Phase 1)Study completedNCT01702857
What this trial is testing

A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)

Who this might be right for
Dengue Fever
U.S. Army Medical Research and Development Command 100
Large-scale testing (Phase 3)UnknownNCT00966628
What this trial is testing

Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)

Who this might be right for
Dengue Shock Syndrome
Innogene Kalbiotech Pte. Ltd 50
Testing effectiveness (Phase 2)Study completedNCT02628444
What this trial is testing

Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 1,050
Large-scale testing (Phase 3)Study completedNCT02993757
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 528
Early research (Phase 1)Study completedNCT00919178
What this trial is testing

Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus

Who this might be right for
Dengue Shock SyndromeDengue Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases (NIAID) 70
Not applicableStudy completedNCT07621848
What this trial is testing

Abdominal Sonographic Findings and Their Association With Thrombocytopenia in Dengue Fever: A Cross-Sectional Study From an Endemic Region

Who this might be right for
Dengue Fever
National Center for Gastroentestinal and Liver Disease 150
Not applicableStudy completedNCT04048837
What this trial is testing

Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore

Who this might be right for
Dengue Hemorrhagic FeverDengue Shock SyndromeSevere Dengue
National University Hospital, Singapore 200
Early research (Phase 1)Study completedNCT00322946
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 84
Testing effectiveness (Phase 2)Study completedNCT02741128
What this trial is testing

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Immunodeficiency Virus
Sanofi Pasteur, a Sanofi Company 133
Early research (Phase 1)Study completedNCT00831012
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy Adults

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 56
Large-scale testing (Phase 3)Study completedNCT01374516
What this trial is testing

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue
Sanofi Pasteur, a Sanofi Company 20,869
Early research (Phase 1)Study completedNCT00458120
What this trial is testing

Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus

Who this might be right for
Dengue Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Study completedNCT00842530
What this trial is testing

Efficacy and Safety of Dengue Vaccine in Healthy Children

Who this might be right for
Dengue VirusDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi Pasteur, a Sanofi Company 4,002
Early research (Phase 1)Study completedNCT00473135
What this trial is testing

Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Study completedNCT01134263
What this trial is testing

Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 715
Large-scale testing (Phase 3)Study completedNCT01373281
What this trial is testing

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 10,275
Large-scale testing (Phase 3)Study completedNCT01254422
What this trial is testing

Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi 250
Early research (Phase 1)Study completedNCT01084291
What this trial is testing

Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine

Who this might be right for
Dengue Virus
National Institute of Allergy and Infectious Diseases (NIAID) 18
Load More Results